Argitalpenak (7) ROSALIA ALONSO TRILLO argitalpenak

2024

  1. Mesenchymal stromal cell therapy for COVID-19 acute respiratory distress syndrome: a double-blind randomised controlled trial

    Bone Marrow Transplantation, Vol. 59, Núm. 6, pp. 777-784

2021

  1. Double-blind, randomized, controlled, trial to assess the efficacy of allogenic mesenchymal stromal cells in patients with acute respiratory distress syndrome due to COVID-19 (COVID-AT): A structured summary of a study protocol for a randomised controlled trial

    Trials

  2. The International Prognostic Index Is Associated with Outcomes in Diffuse Large B Cell Lymphoma after Chimeric Antigen Receptor T Cell Therapy

    TRANSPLANTATION AND CELLULAR THERAPY, Vol. 27, Núm. 3, pp. 233-240

2020

  1. Potential Survival Benefit for Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation after Nivolumab Therapy for Relapse/Refractory Hodgkin Lymphoma: Real-Life Experience in Spain

    Biology of Blood and Marrow Transplantation, Vol. 26, Núm. 8, pp. 1534-1542

  2. Three planets transiting the evolved star EPIC 249893012: A hot 8.8-M super-Earth and two warm 14.7 and 10.2-M sub-Neptunes

    Astronomy and Astrophysics, Vol. 636

2019

  1. A paired trial comparing mononuclear cell collection in two machines for further inactivation through an inline or offline extracorporeal photopheresis procedure

    Transfusion, Vol. 59, Núm. 1, pp. 340-346

2018

  1. Intrathecal administration of autologous mesenchymal stromal cells for spinal cord injury: Safety and efficacy of the 100/3 guideline

    Cytotherapy, Vol. 20, Núm. 6, pp. 806-819